Microencapsulation Market 2018 Key Player BASF, Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer

A Microencapsulation Market research report compiled by Global Market Insights, Inc., claims that Europe and North America conjointly held more than 65% of the global share in 2016, owing to the robust expansion of the pharma and healthcare spheres across these highly developed geographies. Primarily, microencapsulation market size across these regions is heavily driven by the growing demand for microencapsulated drugs, not to mention, the extensive R&D activities in the healthcare field. In effect, the growth of the overall pharma sector is directly proportional to the revenue graph of microencapsulation industry share.

Request for a sample copy of this report @
www.gminsights.com/request-sample/detail/2107

The recent Frutarom-AB-Biotics agreement has sent out waves of anticipation in microencapsulation market, given that the deal has been signed by Frutarom to acquire AB Biotics’ iron deficiency ingredient unit, AB-Fortis. Apparently, the Israel-based flavor company plans to encompass AB-Fortis into its established framework of specialty fine ingredients, and tap into its microencapsulation technology to increase the absorbability of iron in tissues, and enable a reduced iron dosage in ingredient extracts, without any side effects or any compromise on the taste factor.

With the acquisition of AB-Fortis, Frutarom has successfully crossed a double benchmark – that of having firmly established its space in microencapsulation industry, while simultaneously having made its tenth acquisition of 2017 so far, the last one being, 210-million-dollar takeover of the Israel ingredients company, Enzymotec. Furthermore, it is prudent to mention that AB-Fortis’ inclusion within Frutarom’s umbrella may prove to be highly beneficial for the ex-iron-deficiency-ingredient unit of the Spanish biotech company AB-Biotics. Considering the prominence of Frutarom in the growing specialty health ingredients market, it is expected that the company will exploit the full potential of AB-Fortis to mark a precedence in the microencapsulation market as well.

Microencapsulation technology finds extensive applications across a plethora of end-use domains, though the pharmaceutical sphere, by far, remains one of the most lucrative sectors. In 2016 alone, the pharma domain accounted for a revenue of USD 4 billion from the overall microencapsulation industry share, driven by the deployment of this technology for improving the process and effectiveness of drug delivery and camouflage the bitter taste of medicines.

Browse Complete Report Summary @
https://www.gminsights.com/industry-analysis/microencapsulation-market

Also, this sector has achieved commendable prominence in the developed regions of the globe, thereby providing an impetus to the overall microencapsulation market size. As per statistics, the pharma sector in North America is in exceedingly good shape, driven by the contribution of the United States, which is touted to be the most important pharmaceutical market is the world. In conjunction with Mexico and Canada in fact, it represents the biggest continental pharmaceutical business globally, which is evidence enough to claim that North America is one of most remunerative grounds for microencapsulation industry. Estimates state that the U.S. alone accounts for more than 45% of the overall pharma business – in 2016, its contribution toward the global pharma sphere has been touted to be around USD 446 billion. Given the robust expansion of this sector in the U.S., it has been forecast that U.S. microencapsulation market share is likely to accumulate substantial revenue in the ensuing years.

Partial Chapter of the Table of Content

Chapter 3. Microencapsulation Industry Insights

3.1. Industry segmentation
3.2. Industry size and forecast, 2013 - 2024
3.3. Industry ecosystem analysis
3.3.1. Vendor matrix
3.3.2. Distributor channel analysis
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Rising trend of functional foods
3.4.1.2. Increasing acceptance of specialty detergents & cleaning agents
3.4.1.3. Growth in pharmaceutical industry
3.4.2. Industry pitfalls & challenges
3.4.2.1. Requirement of extensive research for appropriate technology and core materials
3.5. Growth potential analysis
3.6. Technology trends
3.7. Regulatory trends
3.8. Porter’s analysis
3.9. Company market share analysis, 2016
3.9.1. Strategic landscape
3.10. PESTEL analysis
3.11. Regional price trends

Make an inquiry for purchasing this report @
www.gminsights.com/inquiry-before-buying/2107

Chapter 4. Microencapsulation Market, By Technology

4.1. Global microencapsulation market share by technology, 2016 & 2024
4.2. Chemical
4.2.1. Market estimates and forecasts, 2013 - 2024
4.2.2. Market estimates and forecasts by region, 2013 – 2024
4.3. Physiochemical
4.3.1. Market estimates and forecasts, 2013 - 2024
4.3.2. Market estimates and forecasts by region, 2013 – 2024
4.4. Electrostatic
4.4.1. Market estimates and forecasts, 2013 - 2024
4.4.2. Market estimates and forecasts by region, 2013 – 2024
4.5. Mechanical
4.5.1. Market estimates and forecasts, 2013 - 2024
4.5.2. Market estimates and forecasts by region, 2013 – 2024

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

This release was published on openPR.